Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study
NCT07245667
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Tinea Pedis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Propedix, Inc.
- Last updated on ClinicalTrials.gov
- November 28, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 2
- Kuchnir Dermatology and Dermatological Surgery · Framingham, MA
- Kuchnir Dermatology and Dermatological Surgery · Milford, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.